Status:
COMPLETED
Study of Tai Chi Exercise and Balance in Persons With Parkinson's Disease
Lead Sponsor:
Oregon Research Institute
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Parkinson's Disease
Eligibility:
All Genders
40-85 years
Phase:
PHASE2
Brief Summary
Patients practicing Tai Chi will exhibit significant improvements in primary outcome measures of balance, and secondary outcomes of gait, physical performance, Unified Parkinson's Disease Rating Scale...
Detailed Description
The study is designed to determine the effects of Tai Chi training on balance and other functional outcomes in persons with Parkinson's disease.
Eligibility Criteria
Inclusion
- Patients who have:
- A diagnosis of idiopathic PD, with a disease severity rating of stage I to IV on the Hoehn and Yahr scale (Hoehn \& Yahr, 1967)
- At least 1 score of 2 or more for at least 1 limb for either the tremor, rigidity, or bradykinesia item of the Unified Parkinson's Disease Rating Scale (UPDRS)
- Stable medication usage
- Not participated in a structured exercise program (i.e., not involved in any routine, organized physical activity program lasting 30 minutes or more per day, such as a gym program or regularly scheduled instructor-led exercise class) in the previous 2 months
- Ability to stand unaided or walk independently; had a personal physician's or neurologist's clearance for participation; and had a willingness to be assigned to intervention conditions.
Exclusion
- Patients who:
- Participate in any other behavioral or pharmacological research study
- Have cognitive decline (Mini-Mental State Examination score, ≤ 24) (Folstein et al., 1975)
- Have self-reported diagnosis of Alzheimer disease or other severe neurological (stage III and IV PD)
- Have evidence of progressive or debilitating conditions (metastatic cancer, severe heart or lung disease, crippling arthritis) or severe losses in vision and hearing that would limit their tolerance to testing and training procedures, that would interfere with study participation
- Are unavailable during the study period.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT00611481
Start Date
October 1 2008
End Date
August 1 2011
Last Update
October 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Research Institute
Eugene, Oregon, United States, 97403